$3.83
-0.055-1.41%
Last update: Nov 16, 10:33 AM

The average analyst price target for ARS Pharmaceuticals is $24, 525.8% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $17 to $40. The latest change came on Nov 6, 2026, when Cantor Fitzgerald lowered its price target on ARS Pharmaceuticals from $30 to $20 and kept an Overweight rating.
Price Target Range — 8 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months